GU Cancer Forum Lausanne 2027 is an important Swiss oncology event focused on the latest developments in the diagnosis and treatment of genitourinary cancers. The forum brings together oncologists, urologists, radiation oncologists, researchers, and other healthcare professionals to exchange knowledge and discuss clinically relevant advances in urogenital oncology.

The programme provides a concise review of key findings from leading international congresses, including ASCO GU, EAU, AUA, ASCO, ESMO, ESTRO, and ASTRO. Particular attention is given to major developments in prostate cancer and urothelial carcinoma, as well as emerging treatment strategies and their implications for clinical practice.

Key topics include prostate cancer, urothelial cancer, genitourinary oncology, systemic therapies, immunotherapy, targeted treatments, radiotherapy, surgical oncology, precision medicine, clinical trials, and new evidence from international cancer conferences.

The GU Cancer Forum Lausanne 2027 offers an efficient platform for continuing medical education, interdisciplinary discussion, and professional networking. By presenting the most relevant international oncology developments in a focused format, the forum helps specialists stay informed about rapidly evolving treatment standards and new therapeutic approaches.